Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

27. April 2020 10:15 ET | Quelle: Virscio

Virscio Publishes Data Validating Non-Human Primate Model for Testing Chronic Retinal Neovascularization and Vascular Leakage Drug Candidates

Findings published in peer-reviewed Experimental Eye Research Establishment of NHP model meaningfully de-risks drug candidates for severe, prevalent retinal diseases responsible for vision loss NEW...
08. Januar 2020 10:15 ET | Quelle: Virscio

RxGen Rebrands as Virscio to Reflect Corporate Growth and Enhanced Focus on Comprehensive Suite of Preclinical Research Offerings and Capabilities

NEW HAVEN, Conn., Jan. 08, 2020 (GLOBE NEWSWIRE) -- RxGen, a translational research company ensuring definitive, actionable preclinical outcomes through the use of predictive, validated disease...
14. Oktober 2019 10:17 ET | Quelle: RxGen

RxGen to Present Alzheimer’s Disease APP/Abeta Cellular and Animal Models at the Society for Neuroscience’s 49th Annual Meeting

NEW HAVEN, Conn., Oct. 14, 2019 (GLOBE NEWSWIRE) -- RxGen, a preclinical translational research company, will be presenting a poster highlighting its progress in advancing preclinical models of...
22. April 2019 08:56 ET | Quelle: RxGen

RxGen to Deliver Multiple Presentations at Association for Research in Vision and Ophthalmology Annual Meeting

NEW HAVEN, Conn., April 22, 2019 (GLOBE NEWSWIRE) -- RxGen, a preclinical translational research company, today announced that the company will be presenting at the Association for Research in...